Crinetics Pharmaceuticals Inc (CRNX) Insider Trading
- $45,793,090.74
- $78,827,804.57
- Oct. 3, 2024
- Stephen F Betz
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 15, 2022 | Insider | 4,168 | $21.01 | Sell | $87,569.68 | |
Sept. 7, 2022 | Insider | 1,042 | $21.00 | Sell | $21,882.00 | |
July 26, 2022 | COO | 1,152 | $20.70 | Sell | $23,846.40 | |
July 13, 2022 | Director | 5,700 | $20.96 | Sell | $119,472.00 | |
July 13, 2022 | N/A | 5,700 | $20.96 | Sell | $119,472.00 | |
May 2, 2022 | Insider | 3,247 | $20.10 | Sell | $65,264.70 | |
April 18, 2022 | Insider | 5,664 | $25.81 | Sell | $146,187.84 | |
April 18, 2022 | Major Shareholder | 157,515 | $22.22 | Buy | $3,499,983.30 | |
April 13, 2022 | CEO | 138,643 | $26.83 | Sell | $3,719,791.69 | |
April 5, 2022 | CEO | 21,357 | $25.34 | Sell | $541,186.38 | |
April 4, 2022 | Insider | 9,000 | $23.97 | Sell | $215,730.00 | |
March 31, 2022 | Insider | 4,164 | $21.06 | Sell | $87,693.84 | |
March 1, 2022 | Insider | 3,123 | $19.73 | Sell | $61,616.79 | |
Feb. 7, 2022 | Insider | 13,411 | $17.83 | Sell | $239,118.13 | |
Feb. 1, 2022 | Insider | 3,123 | $18.79 | Sell | $58,681.17 | |
Jan. 18, 2022 | Insider | 4,168 | $23.29 | Sell | $97,072.72 | |
Jan. 3, 2022 | Insider | 7,168 | $28.02 | Sell | $200,847.36 | |
Dec. 28, 2021 | Insider | 3,000 | $27.95 | Sell | $83,850.00 | |
Dec. 15, 2021 | Insider | 5,668 | $24.14 | Sell | $136,825.52 | |
Dec. 1, 2021 | Insider | 5,668 | $27.38 | Sell | $155,189.84 | |
Nov. 8, 2021 | Insider | 3,900 | $28.42 | Sell | $110,838.00 | |
Nov. 5, 2021 | Insider | 12,600 | $27.95 | Sell | $352,170.00 | |
Nov. 1, 2021 | Director | 8,954 | $25.50 | Sell | $228,327.00 | |
Nov. 1, 2021 | Insider | 5,668 | $24.79 | Sell | $140,509.72 | |
Oct. 27, 2021 | Insider | 3,000 | $24.00 | Sell | $72,000.00 | |
Oct. 25, 2021 | Major Shareholder | 1,200,000 | $19.80 | Buy | $23,760,000.00 | |
Oct. 21, 2021 | Insider | 1,042 | $21.10 | Sell | $21,986.20 | |
Sept. 8, 2021 | Director | 6,046 | $25.50 | Sell | $154,173.00 | |
Sept. 7, 2021 | CEO | 30,000 | $25.00 | Sell | $750,000.00 | |
July 26, 2021 | Director | 5,000 | $19.59 | Sell | $97,950.00 | |
July 19, 2021 | Director | 5,000 | $19.50 | Sell | $97,500.00 | |
July 12, 2021 | Director | 5,000 | $20.71 | Sell | $103,550.00 | |
April 8, 2021 | Major Shareholder | 304,136 | $16.44 | Buy | $4,999,995.84 | |
Dec. 2, 2020 | CEO | 1,000 | $12.60 | Buy | $12,600.00 | |
July 15, 2020 | CEO | 17,500 | $15.30 | Sell | $267,750.00 | |
April 17, 2020 | Major Shareholder | 84,598 | $15.40 | Sell | $1,302,809.20 | |
April 15, 2020 | Major Shareholder | 215,810 | $15.50 | Sell | $3,345,055.00 | |
April 7, 2020 | Major Shareholder | 6,115 | $14.20 | Sell | $86,833.00 | |
April 3, 2020 | Major Shareholder | 300,000 | $13.80 | Sell | $4,140,000.00 | |
March 9, 2020 | Major Shareholder | 528 | $19.50 | Sell | $10,296.00 | |
Feb. 10, 2020 | Major Shareholder | 7,555 | $21.40 | Sell | $161,677.00 | |
Feb. 7, 2020 | Major Shareholder | 5,905 | $22.00 | Sell | $129,910.00 | |
Feb. 4, 2020 | Major Shareholder | 13,460 | $22.80 | Sell | $306,888.00 | |
Jan. 31, 2020 | Major Shareholder | 5,400 | $21.70 | Sell | $117,180.00 | |
Jan. 29, 2020 | Major Shareholder | 13,920 | $22.20 | Sell | $309,024.00 | |
Dec. 16, 2019 | Director | 3,500 | $22.50 | Sell | $78,750.00 | |
June 21, 2019 | Insider | 250,000 | $22.20 | Sell | $5,550,000.00 | |
March 20, 2019 | Major Shareholder | 417,000 | $22.25 | Sell | $9,278,250.00 | |
March 18, 2019 | Major Shareholder | 154,839 | $24.25 | Sell | $3,754,845.75 | |
Jan. 22, 2019 | Major Shareholder | 262,153 | $21.88 | Sell | $5,735,907.64 |
Insiders are both buying and selling Crinetics Pharmaceuticals Inc stock.
The insider traders at Crinetics Pharmaceuticals Inc are: Stephen F Betz, Vivo Capital Viii, Llc, Richard Scott Struthers, Marc Wilson, Dana Pizzuti, Matthew K Fust, Jeff E Knight, Perceptive Advisors Llc, Ventures Iv L.P. 5Am, James Hassard, Alan Seth Krasner, Fust Matthew K, Stephanie Okey, Coelho Rogerio Vivaldi, Ajay Madan, Vivo Capital Fund Viii, L.P., and Life Sciences Maste Perceptive
The most active insider trader at Crinetics Pharmaceuticals Inc is Stephen F Betz with 37 trades.
Richard Scott Struthers has sold the most Crinetics Pharmaceuticals Inc stock with a total value of $25,811,785.77.
Perceptive Advisors Llc has bought the most Crinetics Pharmaceuticals Inc stock with a total value of $35,759,962.44.
The most recent insider trade for Crinetics Pharmaceuticals Inc was on Oct. 3, 2024.
The single biggest insider buy for Crinetics Pharmaceuticals Inc was from Perceptive Advisors Llc with a total value of $23,760,000.00 on Oct. 25, 2021.
The single biggest insider sell for Crinetics Pharmaceuticals Inc was from Vivo Capital Fund Viii, L.P. with a total value of $9,278,250.00 on March 20, 2019.